BPC-157 + TB-500
bpc-157-tb-500 appears in 1,423 indexed publications going back to 1982, including 76 in the past twelve months. 19 registered trials appear on ClinicalTrials.gov.
On This Figure
BPC-157 + TB-500 is a blend. These figures combine its components (BPC-157, TB-500), so totals are an upper bound where a single paper covers more than one of them.
Publication history
How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.
Publications per year. The final bar is the current year, still in progress.
| 2015 | 5 |
|---|---|
| 2016 | 8 |
| 2017 | 11 |
| 2018 | 9 |
| 2019 | 6 |
| 2020 | 11 |
| 2021 | 19 |
| 2022 | 12 |
| 2023 | 10 |
| 2024 | 5 |
| 2025 | 19 |
| 2026 | 37 |
Who is looking it up
Monthly readers of the BPC-157 + TB-500 article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.
The registered pipeline
Phase distribution across the most recently updated registered trials.
- Not yet recruiting·Phase 1
Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery
University of Arkansas · estimated completion 2027-08-01
- Completed·Not applicable
Parlay Wellness · completed 2025-11-01
- Recruiting·Phase 2
BPC 157 for Acute Hamstring Muscle Strain Repair
Hudson Biotech · estimated completion 2027-02-14
- Status unknown·Phase 1
PCO-02 - Safety and Pharmacokinetics Trial
PharmaCotherapia d.o.o. · completed 2016-02
- Completed·Phase 3
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
ReGenTree, LLC · completed 2017-09
- Completed·Phase 3
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
ReGenTree, LLC · completed 2020-11-08
Most recent work
The newest indexed records mentioning BPC-157 + TB-500, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.
- 2026-10-08·Acta orthopaedica Belgica
Poolton JT, Minett J, Kazmi A. et al.
- 2026-09-19·International journal of molecular sciences
BPC 157 in Rodent Ischemia-Reperfusion Injury: A Critical Review of Preclinical Evidence
Demirtaş H. et al.
- 2026-08-29·Applied biochemistry and biotechnology
Efficient Expression of Small Molecule Bioactive Peptides in Bacillus licheniformis
Zhang H, Shao L, Feng Q et al.
- 2026-08-24·Current pain and headache reports
Luansritisakul C, Chiang MC, Burns SL et al.
- 2026-08-17·Molecular biomedicine
Zhao TR, Hu EB, Wang MW et al.
- 2026-08-11·The American journal of sports medicine
Peptide Supplements and Their Therapeutic Applications in Sports Medicine
Tewari K, Liu TP, Im C et al.
- 2026-08-01·Clinical science (London, England : 1979)
Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway
Ouyang X, Long Z, Xu X et al.
- 2026-07-23·Joint diseases and related surgery
Biçer O, Adanir O, Güleryüz Y et al.
BPC-157 + TB-500 available from Polaris Research
Supplied as research materials for laboratory use. Free express delivery Australia wide.
Sources
Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-10-25.